Octimet Oncology Was Founded In 2016 By Timothy Perera Phdann Meulemans Phdpaolo Comogliomdphd And Philip Owen Headed By Drtimothy Pereraceo Octimet Has Licensed Highly Selective Met Kinase Inhibitors With Clean Safety Profiles From Janssen Pharmaceutica And Will Advance The Development Of These Molecules By Employing Innovative Patient Selection And Pharmacodynamic Biomarker Based Strategiesas Well As An Innovative Clinical Development Strategyto Provide Differentiation Both Within The Current Treatment Paradigms And From Competitor Agents Using Biomarker Defined Intelligent Patient Selection
No conferences found for this company.
| Company Name | Octimet Oncology Nv |
| Country |
Belgium
|
| Address | N/A |
| Telephone | N/A |
| N/A |
